Today’s Market Runner: Monsanto Co (NYSE:MON) 2016 Q2 Sentiment

November 24, 2016 - By Ellis Scott   ·   0 Comments

Today's Market Runner: Monsanto Co (NYSE:MON)  2016 Q2 Sentiment

Sentiment for Monsanto Co (NYSE:MON)

Monsanto Co (NYSE:MON) institutional sentiment increased to 1.02 in 2016 Q2. Its up 0.11, from 0.91 in 2016Q1. The ratio is positive, as 385 institutional investors started new or increased stock positions, while 422 sold and decreased stock positions in Monsanto Co. The institutional investors in our partner’s database now own: 338.57 million shares, down from 355.97 million shares in 2016Q1. Also, the number of institutional investors holding Monsanto Co in their top 10 stock positions increased from 16 to 34 for an increase of 18. Sold All: 88 Reduced: 334 Increased: 243 New Position: 142.

Monsanto Company , along with its subsidiaries, is a well-known provider of agricultural products for farmers. The company has a market cap of $45.15 billion. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. It has a 34.09 P/E ratio. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.

The stock increased 0.66% or $0.67 on November 23, hitting $102.42. Monsanto Company (NYSE:MON) has risen 8.86% since April 22, 2016 and is uptrending. It has outperformed by 3.46% the S&P500.

Analysts await Monsanto Company (NYSE:MON) to report earnings on January, 5 before the open. They expect $-0.04 EPS, up 63.64% or $0.07 from last year’s $-0.11 per share. After $0.07 actual EPS reported by Monsanto Company for the previous quarter, Wall Street now forecasts -157.14% negative EPS growth.

According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”

Sheffield Asset Management L.L.C. holds 15.58% of its portfolio in Monsanto Company for 506,300 shares. Trinity Street Asset Management Llp owns 451,991 shares or 10.86% of their US portfolio. Moreover, Marianas Fund Management Llc has 9% invested in the company for 420,500 shares. The Missouri-based Plancorp Llc has invested 8.65% in the stock. R. G. Niederhoffer Capital Management Inc, a New York-based fund reported 12,200 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 1 insider purchase, and 3 insider sales for $8.18 million net activity.

Monsanto Company (NYSE:MON) Ratings Coverage

Ratings analysis reveals 67% of Monsanto Company’s analysts are positive. Out of 21 Wall Street analysts rating Monsanto Company, 14 give it “Buy”, 1 “Sell” rating, while 6 recommend “Hold”. The lowest target is $83 while the high is $134. The stock’s average target of $112.06 is 9.41% above today’s ($102.42) share price. MON was included in 40 notes of analysts from August 25, 2015. Piper Jaffray maintained the stock with “Overweight” rating in Thursday, August 27 report. The stock of Monsanto Company (NYSE:MON) earned “Equal Weight” rating by Barclays Capital on Thursday, January 7. The rating was initiated by Bernstein on Friday, September 11 with “Underperform”. The stock of Monsanto Company (NYSE:MON) has “Overweight” rating given on Thursday, August 27 by Morgan Stanley. On Thursday, April 7 the stock rating was maintained by Citigroup with “Neutral”. Citigroup maintained the shares of MON in a report on Friday, July 1 with “Neutral” rating. Goldman Sachs reinitiated the stock with “Neutral” rating in Wednesday, September 23 report. Goldman Sachs upgraded Monsanto Company (NYSE:MON) on Tuesday, September 27 to “Neutral” rating. The rating was maintained by Goldman Sachs with “Sell” on Monday, April 11. The firm has “Buy” rating by Monness Crespi given on Monday, October 3.

MON Company Profile

Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.

More important recent Monsanto Company (NYSE:MON) news were published by: Wsj.com which released: “Monsanto to Buy European Farm Software Company” on November 21, 2016, also Tucson.com published article titled: “Pima County supervisors postpone vote on tax breaks for Monsanto”, Tucson.com published: “Critics decry tax breaks as Monsanto plans Marana greenhouse” on November 19, 2016. More interesting news about Monsanto Company (NYSE:MON) was released by: Wsj.com and their article: “Bayer CEO Defends Planned Acquisition of Monsanto” with publication date: October 26, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ellis Scott


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>